Riskpilot← Back to searchSign inGet full accessPROXEON BIOSYSTEMS ApS
APSActiveCVR 26848024Kamstrupvej 90Research and experimental development on natural sciences and engineering · NACE 7210Est. 2002— employees
Revenue 2024
DKK 0
EBITDA margin
—
-101% vs 2023
Equity ratio
97.2%
Financial strength
Net profit 2024
DKK 3,7M
+150% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -403K | -101% |
| Net profit | DKK 3,7M | +150% |
| Total assets | DKK 394,5M | +1% |
| Equity | DKK 383,6M | +1% |
| Employees | — | — |
Legal name
PROXEON BIOSYSTEMS ApS
CVR number
26848024
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. oktober 2002
Share capital
DKK 4.000.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med et bestyrelsesmedlem, af en direktør i forening med et bestyrelsesmedlem samt af den samlede bestyrelse.
Company purpose
Selskabets formål er at udvikle og markedsføre teknologi, apparatur og forbrugsvarer til anvendelse i bioteknologisk forskning og klinisk behandling og anden hermed forbunden virksomhed.
Address
Kamstrupvej 90
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37.938 | 48.415 | 58.387 | 63.956 | 39.918 | 37.968 | 47.689 | 42.034 | 20.729 | 30.910 | 39.387 | 36.919 | 0 |
| Staff expenses | -19.308 | -16.347 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 29.440 | 40.587 | 54.838 | 63.891 | 39.691 | 37.831 | 46.853 | 41.481 | 20.243 | 30.708 | 39.123 | 36.617 | -403 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 29.440 | 40.587 | 54.838 | 63.891 | 39.691 | 37.831 | 46.853 | 41.481 | 20.243 | 30.708 | 39.123 | 36.617 | -403 |
| Net financials | -104 | -874 | 1.498 | 5.150 | 157 | -29 | -383 | -29 | -165 | -26 | -98 | 4.733 | 8.159 |
| Profit before tax | 29.381 | 39.712 | 56.622 | 69.041 | 39.848 | 37.802 | 46.470 | 41.452 | 20.078 | 30.682 | 39.025 | 41.350 | 7.756 |
| Tax | 7.348 | 10.023 | 11.134 | 18.921 | 8.766 | 8.316 | 10.224 | 9.120 | 4.417 | 6.750 | 8.632 | 48.782 | 4.053 |
| Net profit | 22.033 | 29.689 | 45.488 | 50.120 | 31.081 | 29.486 | 36.246 | 32.332 | 15.661 | 23.932 | 30.393 | -7.432 | 3.703 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 72.601 | 108.454 | 159.445 | 207.395 | 229.117 | 258.092 | 295.865 | 327.010 | 337.695 | 363.853 | 387.442 | 389.132 | 394.523 |
| Equity | 62.980 | 92.631 | 138.119 | 188.239 | 219.321 | 248.807 | 285.053 | 317.383 | 333.044 | 356.976 | 387.369 | 379.937 | 383.640 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8.811 | 14.828 | 21.326 | 19.155 | 9.796 | 9.285 | 10.812 | 9.627 | 4.651 | 6.877 | 73 | 9.195 | 10.883 |
| Total debt | 8.811 | 14.828 | 21.326 | 19.155 | 9.796 | 9.285 | 10.812 | 9.627 | 4.651 | 6.877 | 73 | 9.195 | 10.883 |
EBITDA margin
-40300000.0%
This company
15.8%
Market median
-255063391% vs market
20122024
Equity ratio
97.2%
This company
38.2%
Market median
+154% vs market
20122024
Return on equity
1.0%
This company
18.4%
Market median
-95% vs market
20122024
Net profit margin
370300000.0%
This company
8.1%
Market median
+4571604838% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SL Management | Management | 2023 | — | — |
MW Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
TW Audit | Audit | 2002 | — | — |
GH Management | Management | 2014 | — | — |
OV Chief Executive Officer | Chief Executive Officer | 2002 | — | — |
BK Management | Management | 2020 | — | — |
MT Management | Management | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2006 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2017 | — | — | |
| Chairman | 2002 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2003 | — | — | |
| Board of Directors | 2015 | — | — | |
| Chairman | 2005 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NUNC A/S | Company | 100.0% | 100.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NUNC A/S
PROXEON BIOSYSTEMS ApS Board members of PROXEON BIOSYSTEMS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Simon Lie | Management | 0 companies |
| Mårten Winge | Chief Executive Officer | 0 companies |
| Torben Wied | Audit | 0 companies |
| Grant Hellier Lawrence | Management | 0 companies |
| Ole Vorm | Chief Executive Officer | 0 companies |
| Bo Kühnel Matthisson | Management | 0 companies |
| Michael Toftvad | Management | 0 companies |
| Erik Johan Lennart Walldén | Board of Directors | 0 companies |
| Jarne Elleholm | Board of Directors | 0 companies |
| James R. Coley | Board of Directors | 0 companies |
| Tonni Bülow-Nielsen | Board of Directors | 0 companies |
| Thomas Graf | Board of Directors | 0 companies |
| Palle Schelde Jensen | Board of Directors | 0 companies |
| Rikhard Zitting | Board of Directors | 0 companies |
| Anthony Hugh Smith | Board of Directors | 0 companies |
| Hans Schmidt-Hansen | Chairman | 0 companies |
| John Riis Mortensen | Board of Directors | 0 companies |
| Hans-Henrik Horsted Eriksen | Board of Directors | 0 companies |
| Iain Alasdair Keith Moodie | Board of Directors | 0 companies |
| Lars Fogh | Chairman | 0 companies |
| Linda Carina Carlsson | Board of Directors | 0 companies |
| Patrik Olof Dahlén | Chairman | 0 companies |
| Piet Van der Zande | Chairman | 0 companies |
| Paul-Christian Sonne Kongsted | Board of Directors | 0 companies |